Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin (Q39710105)
Jump to navigation
Jump to search
scientific article published on 27 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin |
scientific article published on 27 April 2010 |
Statements
1 reference
Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin (English)
1 reference
Tanvi S Jani
1 reference
Jennifer DeVecchio
1 reference
Tapati Mazumdar
1 reference
Akwasi Agyeman
1 reference
Janet A Houghton
1 reference
27 April 2010
1 reference
1 reference
285
1 reference
25
1 reference
19162-19172
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference